Starpharma Holdings Ltd (SPL):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Starpharma Holdings Ltd (SPL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7482
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Starpharma Holdings Ltd (Starpharma) is a biotechnology company, which researches, develops and manufactures dendrimer products for pharmaceutical, life sciences and other applications. Dendrimers are synthetic nanoscale polymers with pharmaceutical and medical uses. The company’s development programs include its DEP drug delivery, which is built around dendrimers, VivaGel portfolio and agrochemicals. Its flagship product candidate, VivaGel, is a gel-based formulation for the treatment and prevention of bacterial vaginosis (BV) and it is also used as a vaginal microbicide to prevent sexually transmitted infections including HIV and genital herpes. The company has license arrangements with several partners including Ansell Limited, Aspen Pharmacare, Okamoto Industries and AstraZeneca. The company has research facilities in Melbourne, Australia. Starpharma is headquartered in Melbourne, Australia.

Starpharma Holdings Ltd (SPL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Starpharma Holdings Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Starpharma Holdings Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Starpharma Holdings Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Starpharma Holdings Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Starpharma Holdings Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Starpharma Holdings Ltd, Medical Equipment, Deal Details 10
Mundipharma Enters into Licensing Agreement with Starpharma Holding 10
Starpharma Holdings Enters into Licensing Agreement with Koushan Pharmed 11
Aspen Pharma Enters into Licensing Agreement with Starpharma 12
Starpharma Holdings Ltd – Key Competitors 13
Starpharma Holdings Ltd – Key Employees 14
Starpharma Holdings Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Financial Announcements 16
Aug 21, 2018: Starpharma: Annual report and financial results for the year ended 30 June 2018 16
Feb 26, 2018: Starpharma Interim Report and Half-Year Financial Results 17
Aug 28, 2017: Starpharma annual report and full year financial results 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Starpharma Holdings Ltd, Medical Equipment, Key Facts, 2018 2
Starpharma Holdings Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Starpharma Holdings Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Starpharma Holdings Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Starpharma Holdings Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Starpharma Holdings Ltd, Deals By Market, 2012 to YTD 2018 8
Starpharma Holdings Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Mundipharma Enters into Licensing Agreement with Starpharma Holding 10
Starpharma Holdings Enters into Licensing Agreement with Koushan Pharmed 11
Aspen Pharma Enters into Licensing Agreement with Starpharma 12
Starpharma Holdings Ltd, Key Competitors 13
Starpharma Holdings Ltd, Key Employees 14
Starpharma Holdings Ltd, Subsidiaries 15

List of Figures
Starpharma Holdings Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Starpharma Holdings Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Starpharma Holdings Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Starpharma Holdings Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Starpharma Holdings Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Starpharma Holdings Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Starpharma Holdings Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Starpharma Holdings Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Starpharma Holdings Ltd (SPL):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Finastra Group Holdings Limited:企業のM&A・事業提携・投資動向
    Finastra Group Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Finastra Group Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Proactis Holdings Plc (PHD):企業の財務・戦略的SWOT分析
    Summary Proactis Holdings PLC (Proactis) is a technology company. The company develops and provides spend control and eprocurement solutions. It offers various solutions such as purchase-to-pay, eCommerce, source-to-contract, and global framework. It provides source-to-contract solutions for supplie …
  • Endonovo Therapeutics Inc (ENDV):企業の製品パイプライン分析2018
    Summary Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The company’s products include Electroceutical Therapy a FDA-Cleared for the palliative treatment of pain and post-surgical edema and CE Marked …
  • NiSource Inc (NI):企業の財務・戦略的SWOT分析
    NiSource Inc (NI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • X-Chem Inc-製薬・医療分野:企業M&A・提携分析
    Summary X-Chem Inc (X-Chem) is a biotechnology company that focuses on applying its innovative drug discovery platform to the generation of novel small molecule therapeutics. The company’s drug discovery engine is based on a library generated by iterative combinatorial synthesis of small molecules. …
  • Krka, d. d., Novo mesto:企業の戦略・SWOT・財務情報
    Krka, d. d., Novo mesto - Strategy, SWOT and Corporate Finance Report Summary Krka, d. d., Novo mesto - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Microbix Biosystems Inc (MBX):企業の財務・戦略的SWOT分析
    Summary Microbix Biosystems Inc (Microbix) provides biological and technology solutions for human health and wellbeing. The company's products include infectious disease antigens and quality assessment products. It manufactures viral and bacterial antigens and reagents for the diagnostics. Microbix …
  • StealthGas Inc (GASS):企業の財務・戦略的SWOT分析
    Summary StealthGas Inc (StealthGas) is an oil and gas shipping company that offers seaborne and oil and gas transportation services. The company provides transportation of petroleum and petrochemical gas products in liquefied forms. It transports byproducts of crude oil and natural gas including but …
  • MiaSole Hi-Tech Corp:電力:M&Aディール及び事業提携情報
    Summary MiaSole Hi-Tech Corp (MiaSole) is an alternative energy company that manufactures, designs, develops, and markets thin-film photovoltaic solar cells and panels. The company's products include flexible solar cells, custom modules and SolarRide. It offers photovoltaic products for large-scale …
  • Bank of Baroda:企業のM&A・事業提携・投資動向
    Bank of Baroda - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of Baroda Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Sensus Healthcare Inc (SRTS):企業の財務・戦略的SWOT分析
    Sensus Healthcare Inc (SRTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Active Biotech AB (ACTI):企業の財務・戦略的SWOT分析
    Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • vTv Therapeutics Inc (VTVT)-製薬・医療分野:企業M&A・提携分析
    Summary vTv Therapeutics Inc (vTv), formerly TransTech Inc is a clinical stage pharmaceutical company that discovers, develops and commercializes small molecule drug candidates. The company’s pipeline products include azeliragon, TTP399, TTP273, HPP593, HPP737, HPP971 and hexokinase II inhibitors. I …
  • Aerin Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Aerin Medical Inc (Aerin) develops a non-invasive medical device that treats nasal obstruction and breathing disorders. The company develops VIVAER, an advanced treatment platform that treats nasal congestion and remodel nasal soft tissues utilizing low-power radio frequency energy. Its trea …
  • Iberdrola, S.A.:企業の戦略・SWOT・財務分析
    Iberdrola, S.A. - Strategy, SWOT and Corporate Finance Report Summary Iberdrola, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • FLYHT Aerospace Solutions Ltd.:企業の戦略・SWOT・財務分析
    FLYHT Aerospace Solutions Ltd. - Strategy, SWOT and Corporate Finance Report Summary FLYHT Aerospace Solutions Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • HTG Molecular Diagnostics Inc (HTGM):医療機器:M&Aディール及び事業提携情報
    Summary HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems th …
  • Wesfarmers Limited:企業の戦略・SWOT・財務情報
    Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report Summary Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Synchrony Financial:企業の戦略・SWOT・財務分析
    Synchrony Financial - Strategy, SWOT and Corporate Finance Report Summary Synchrony Financial - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CaixaBank SA:企業の戦略・SWOT・財務情報
    CaixaBank SA - Strategy, SWOT and Corporate Finance Report Summary CaixaBank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆